Precigen Inc. Insider Trading

PGEN

Last 12 months

Insiders bought 25K and sold $44.8M on the open market.

12% of the selling was scheduled in advance under 10b5-1 plans. Director Randal J Kirk sold $15.8M on Mar 30 outside a plan.

Net open-market

−$44.8M

1 buy · 18 sales

Under a 10b5-1 plan

12%

of the value sold

Insiders who bought / sold

1 / 7

executives and directors

Last open-market buy

Aug 2026

Aug 21, 2026

Get an email when PGEN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 26	Jeffrey B Kindler Director	SoldNo plan	185,000	$7.44	$1.38M	92%	Form 4
Aug 21 – 25	Rutul R Shah Chief Operating Officer	Sold10b5-1 plan 2 parts	50,000	$7.50 average	375K	9.6%	Form 4
Aug 25	Phil Tennant Chief Commercial Officer	Sold10b5-1 plan	79,166	$7.50	594K	36%	Form 4
Aug 21	Nancy H Agee Director	Bought	3,411	$7.23	25K	1.1%	Form 4
Aug 6	Rutul R Shah Chief Operating Officer	Sold10b5-1 plan	32,739	$6.86	225K	6.6%	Form 4
Aug 3	Rutul R Shah Chief Operating Officer	Sold10b5-1 plan	33,772	$6.50	220K	6.4%	Form 4
Jul 31	Harry Thomasian Jr. Chief Financial Officer	Sold10b5-1 plan	100,000	$6.06	606K	28%	Form 4
Jun 29 – Jul 1	Harry Thomasian Jr. Chief Financial Officer	Sold10b5-1 plan 2 parts	200,000	$5.57 average	$1.11M	36%	Form 4
Jun 29	Rutul R Shah Chief Operating Officer	Sold10b5-1 plan	42,924	$5.85	251K	7.9%	Form 4
Jun 29	Helen Sabzevari President and CEO	Sold10b5-1 plan	346,836	$5.89	$2.04M	8.4%	Form 4
May 28	Harry Thomasian Jr. Chief Financial Officer	SoldNo plan	41,884	$4.36	183K	7.0%	Form 4
May 28	Phil Tennant Chief Commercial Officer	SoldNo plan	30,272	$4.36	132K	18%	Form 4
May 28	Rutul R Shah Chief Operating Officer	SoldNo plan	42,703	$4.36	186K	7.9%	Form 4
May 28	Donald P. Lehr Chief Legal Officer	SoldNo plan	29,131	$4.36	127K	3.7%	Form 4
May 28	Helen Sabzevari President and CEO	SoldNo plan	119,250	$4.36	520K	3.1%	Form 4
Mar 30	Randal J Kirk Director	SoldNo plan 11 parts	4,772,781	$3.30 average	$15.8M	3.9%	Form 4
Dec 22, 2025	Randal J Kirk Director	SoldNo plan 11 parts	1,900,036	$4.18 average	$7.94M	1.5%	Form 4
Dec 12, 2025	Jeffrey B Kindler Director	SoldNo plan	235,467	$3.63	855K	68%	Form 4
Nov 19, 2025 – Nov 21, 2025	Randal J Kirk Director	SoldNo plan 3 parts	2,966,293	$4.14 average	$12.3M	2.3%	Form 4
Sep 29, 2025 – Sep 30, 2025	Jeffrey B Kindler Director	SoldNo plan 2 parts	174,360	$3.47 average	604K	34%	Form 4
Sep 30, 2025	Randal J Kirk Director	SoldNo plan	1,809,667	$3.41	$6.17M	1.4%	Form 4
Sep 29, 2025	Phil Tennant Chief Commercial Officer	Bought	6,000	$3.58	21K	10%	Form 4
Sep 26, 2025	Rutul R Shah Chief Operating Officer	Bought	2,000	$3.40	7K	0.5%	Form 4
Sep 25, 2025 – Sep 26, 2025	Harry Thomasian Jr. Chief Financial Officer	Bought 2 parts	11,216	$3.57 average	40K	2.5%	Form 4
Sep 18, 2025 – Sep 19, 2025	Randal J Kirk Director	SoldNo plan 2 parts	5,000,252	$3.73 average	$18.7M	3.7%	Form 4
Sep 4, 2025	Nancy H Agee Director	Bought	15,000	$4.60	69K	7.4%	Form 4
Aug 19, 2025 – Aug 28, 2025	Nancy H Agee Director	Bought 2 parts	26,005	$3.79 average	99K	15%	Form 4

Aug 26No plan
Jeffrey B Kindler
Director · sold 185,000 at $7.44
$1.38M
92% of stake
Aug 21 – 2510b5-1 plan
Rutul R Shah
Chief Operating Officer · sold 50,000 at avg $7.50
375K
9.6% of stake
Aug 2510b5-1 plan
Phil Tennant
Chief Commercial Officer · sold 79,166 at $7.50
594K
36% of stake
Aug 21
Nancy H Agee
Director · bought 3,411 at $7.23
25K
1.1% of stake
Aug 610b5-1 plan
Rutul R Shah
Chief Operating Officer · sold 32,739 at $6.86
225K
6.6% of stake
Aug 310b5-1 plan
Rutul R Shah
Chief Operating Officer · sold 33,772 at $6.50
220K
6.4% of stake
Jul 3110b5-1 plan
Harry Thomasian Jr.
Chief Financial Officer · sold 100,000 at $6.06
606K
28% of stake
Jun 29 – Jul 110b5-1 plan
Harry Thomasian Jr.
Chief Financial Officer · sold 200,000 at avg $5.57
$1.11M
36% of stake
Jun 2910b5-1 plan
Rutul R Shah
Chief Operating Officer · sold 42,924 at $5.85
251K
7.9% of stake
Jun 2910b5-1 plan
Helen Sabzevari
President and CEO · sold 346,836 at $5.89
$2.04M
8.4% of stake
May 28No plan
Harry Thomasian Jr.
Chief Financial Officer · sold 41,884 at $4.36
183K
7.0% of stake
May 28No plan
Phil Tennant
Chief Commercial Officer · sold 30,272 at $4.36
132K
18% of stake
May 28No plan
Rutul R Shah
Chief Operating Officer · sold 42,703 at $4.36
186K
7.9% of stake
May 28No plan
Donald P. Lehr
Chief Legal Officer · sold 29,131 at $4.36
127K
3.7% of stake
May 28No plan
Helen Sabzevari
President and CEO · sold 119,250 at $4.36
520K
3.1% of stake
Mar 30No plan
Randal J Kirk
Director · sold 4,772,781 at avg $3.30
$15.8M
3.9% of stake
Dec 22, 2025No plan
Randal J Kirk
Director · sold 1,900,036 at avg $4.18
$7.94M
1.5% of stake
Dec 12, 2025No plan
Jeffrey B Kindler
Director · sold 235,467 at $3.63
855K
68% of stake
Nov 19, 2025 – Nov 21, 2025No plan
Randal J Kirk
Director · sold 2,966,293 at avg $4.14
$12.3M
2.3% of stake
Sep 29, 2025 – Sep 30, 2025No plan
Jeffrey B Kindler
Director · sold 174,360 at avg $3.47
604K
34% of stake
Sep 30, 2025No plan
Randal J Kirk
Director · sold 1,809,667 at $3.41
$6.17M
1.4% of stake
Sep 29, 2025
Phil Tennant
Chief Commercial Officer · bought 6,000 at $3.58
21K
10% of stake
Sep 26, 2025
Rutul R Shah
Chief Operating Officer · bought 2,000 at $3.40
7K
0.5% of stake
Sep 25, 2025 – Sep 26, 2025
Harry Thomasian Jr.
Chief Financial Officer · bought 11,216 at avg $3.57
40K
2.5% of stake
Sep 18, 2025 – Sep 19, 2025No plan
Randal J Kirk
Director · sold 5,000,252 at avg $3.73
$18.7M
3.7% of stake
Sep 4, 2025
Nancy H Agee
Director · bought 15,000 at $4.60
69K
7.4% of stake
Aug 19, 2025 – Aug 28, 2025
Nancy H Agee
Director · bought 26,005 at avg $3.79
99K
15% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PGEN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PGEN

CompareIntrinsic value

ZBIOZenas BioPharma, Inc.

$28.46+0.28%10

HOOKHookipa Pharma Inc.

No recent price20

ISCOInternational Stem Cell Corporation

$0.14+0.00%29

BIOABioAge Labs, Inc.

$5.95-0.17%10

CBIOCrescent Biopharma, Inc.

$13.42+2.76%50

ALMSAlumis Inc.

$6.55+0.77%10

ACRSAclaris Therapeutics, Inc.

$3.68-1.60%10

ROIVRoivant Sciences Ltd

$38.23+6.08%16

Held by ETFs

PGEN is in 35 US ETFs. The largest of them, with PGEN's weight in each:

Spot a number that looks wrong? Check it in PGEN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PGEN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.